|
Jan 9
|
Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™, for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) in Kingdom of Saudi Arabia
|
|
Jan 7
|
5 Top Stocks to Buy in January
|
|
Jan 6
|
Is Vertex Pharmaceuticals Stock a Buy Now?
|
|
Jan 5
|
2 Biotech Stocks With Huge Catalysts in 2024
|
|
Jan 4
|
The Best Stocks to Invest $1,000 in Right Now
|
|
Jan 3
|
Vertex Pharmaceuticals (VRTX) Stock Moves -0.05%: What You Should Know
|
|
Jan 3
|
January Has Been 1 of the Worst Months for the S&P 500 Over the Last 20 Years. Here Are 3 Stocks to Buy Anyway.
|
|
Jan 2
|
Editas (EDIT) Stock Gains 23% in the Past 6 Months: Here's Why
|
|
Jan 2
|
10 clinical trials to watch in the first half of 2024
|
|
Jan 1
|
Prediction: These 3 Stocks Will Soar in 2024
|
|
Dec 31
|
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
|
|
Dec 30
|
3 Stocks That Could Be Monster Winners in 2024
|
|
Dec 30
|
Want $1 Million in Retirement? Invest $300,000 in These 3 Stocks and Wait a Decade.
|
|
Dec 29
|
2 Exceptional Growth Stocks Up 42% and 66% to Buy Right Now
|
|
Dec 28
|
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
|
|
Dec 27
|
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
|
|
Dec 23
|
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
|
|
Dec 23
|
5 Top Stocks to Buy With Your End-of-the-Year Bonus
|
|
Dec 22
|
Could CRISPR Therapeutics Stock Help You Become a Millionaire?
|
|
Dec 22
|
Could Sarepta Therapeutics Be the Next Vertex Pharmaceuticals Stock?
|